Ono Pharmaceutical Co., Ltd. (Japan) (OPHLY) Rating Increased to Buy at Citigroup Inc.
Citigroup Inc. upgraded shares of Ono Pharmaceutical Co., Ltd. (Japan) (NASDAQ:OPHLY) from a neutral rating to a buy rating in a research report sent to investors on Thursday morning, The Fly reports.
Shares of Ono Pharmaceutical Co., Ltd. (OPHLY) opened at 7.55 on Thursday. Ono Pharmaceutical Co., Ltd. has a 52-week low of $6.57 and a 52-week high of $10.16. The stock’s 50 day moving average price is $6.90 and its 200-day moving average price is $7.05. The firm has a market capitalization of $11.81 billion and a PE ratio of 24.12.
Receive News & Ratings for Ono Pharmaceutical Co. Ltd. (Japan) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical Co. Ltd. (Japan) and related companies with Analyst Ratings Network's FREE daily email newsletter.